Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank57
5Y CAGR-7.2%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
-7.2%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $709000.00 | +2.2% |
| 2024 | $694000.00 | +101.3% |
| 2023 | $-53.27M | -390.9% |
| 2022 | $-10.85M | -112.1% |
| 2021 | $89.46M | +8568.8% |
| 2020 | $1.03M | -53.3% |
| 2019 | $2.21M | +115.3% |
| 2018 | $-14.43M | - |